Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
val.millar@ndm.ox.ac.uk

Research groups

Cellular High Throughput Screening (HTS)

Val Millar

Recent publications

High-Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers.

Bleloch JS. et al, (2024), Cancer medicine, 13

Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome.

Dombi E. et al, (2024), Frontiers in cell and developmental biology, 12

Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

Rodriguez-Berriguete G. et al, (2023), Clinical Cancer Research, 29, 1631 - 1642

Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis

Gunn PJ. et al, (2020), Physiological Reports, 8

TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions

Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5